Stay updated on Nivolumab and RT in Localized Bladder Cancer Clinical Trial
Sign up to get notified when there's something new on the Nivolumab and RT in Localized Bladder Cancer Clinical Trial page.

Latest updates to the Nivolumab and RT in Localized Bladder Cancer Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2; no study content appears to be affected.SummaryDifference0.1%

- Check19 days agoNo Change Detected
- Check41 days agoChange DetectedAdded Revision: v3.5.0; Deleted Revision: v3.4.3.SummaryDifference0.1%

- Check48 days agoChange DetectedRevision updated: v3.4.3 added and v3.4.2 removed.SummaryDifference0.1%

- Check76 days agoChange DetectedThis page update includes a new revision tag (v3.4.2) and removal of older revision notices (v3.4.1) and a government-funding status notice. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check83 days agoChange DetectedA government funding notice was added stating NIH Clinical Center is open and updates can be found at opm.gov, and the page version was updated from v3.4.0 to v3.4.1; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check90 days agoChange DetectedThe page now includes a glossary toggle and updates several page-labels (Last Update Submitted that Met QC Criteria; No FEAR Act Data) and the revision tag to v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to Nivolumab and RT in Localized Bladder Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab and RT in Localized Bladder Cancer Clinical Trial page.